Search Results

Displaying Results 76-94 of 94 "'SJ'"

Oct 25, 2025, 11:00 ET BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis

et al. Enthesopathies and enthesitis. Part 1. Etiopathogenesis. J Ultrason. 2015;15(60):72-84. Maghsoudlou P, Epps SJ, Guly CM, et al. Uveitis in adults: a review. JAMA. 2025;334(5):419-434. Ogdie A, Weiss P. The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am.

More news about: UCB


Oct 21, 2025, 15:59 ET Elanco Saúde Animal lança Varenzin(TM), primeiro medicamento veterinário oral para tratar anemia em gatos com doença renal crônica (DRC)

2 Polzin DJ. Chronic Kidney Disease. In Ettinger SJ. Feldman SC. Cote E, eds: Textbook of veterinary internal medicine 2017. Ch 324, 1938-59. 8th Edition. Elsevier

More news about: Elanco Saúde Animal


Oct 21, 2025, 10:05 ET Canary Technologies Launches AI-Powered Sales & Catering Payments Hub for Hotels

"Sales processes in hotels have long been bogged down by mundane manual data entry and administrative work, leaving less time for closing business," said SJ Sawhney, Co-Founder and President of Canary Technologies. "With Canary's Sales & Catering Payments Hub, hotels leverage Canary AI to close deals

More news about: Canary Technologies


Oct 16, 2025, 10:30 ET Anvisa aprova nova indicação para durvalumabe da AstraZeneca que reduz em 32% o risco de recidiva no câncer de pulmão operável[1]

Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51; [8] AstraZeneca. Imfinzi prescribing information.[9] Antonia SJ, et al. N Engl J Med. 2017;377(20):1919–29.[10] Paz-Ares L, et al. Lancet. 2019;394(10212):1929-39.[11] Finn RS, et al. J Clin Oncol.

More news about: AstraZeneca


Oct 08, 2025, 09:00 ET Holland America Line Goes Glam with Cruising's First Lipstick Blending Bar at Sea

https://www.cruiseimagelibrary.com/c/pbocu9sj Video is available

More news about: Holland America Line


Oct 08, 2025, 08:30 ET SQ Innovation Announces FDA Approval of Lasix® ONYU for Treatment of Edema in Heart Failure

1 Bozkurt B, Ahmad T, Alexander K, Baker WL, Bosak K, Breathett K, Carter S, Drazner MH, Dunlay SM, Fonarow GC, Greene SJ, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Lee CS, Morris AA, Page RL 2nd, Pandey A, Piano MR, Sandhu AT,

More news about: SQ Innovation


Oct 02, 2025, 21:13 ET OMRON Healthcare übertrifft die Marke von 400 Millionen verkauften Blutdruckmessgeräten

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Bild:

More news about: OMRON HEALTHCARE Co., Ltd.


Oct 02, 2025, 01:46 ET OMRON Healthcare supera los 400 millones de tensiómetros vendidos

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Imagen:

More news about: OMRON HEALTHCARE Co., Ltd.


Oct 01, 2025, 08:02 ET OMRON Healthcare ultrapassa 400 milhões de monitores de pressão arterial vendidos

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Imagem:

More news about: OMRON HEALTHCARE Co., Ltd.


Sep 30, 2025, 02:26 ET OMRON Healthcare dépasse les 400 millions de tensiomètres vendus

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Image :

More news about: OMRON HEALTHCARE Co., Ltd.


Sep 30, 2025, 01:21 ET OMRON Healthcare supera los 400 millones de monitores de presión arterial vendidos

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Imagen:

More news about: OMRON HEALTHCARE Co., Ltd.


Sep 29, 2025, 21:27 ET 歐姆龍健康醫療血壓計銷量突破4億台

Ltd.)宣布,歐姆龍血壓計(BPMs)全球累計銷量已突破4億台。這一里程碑式的成就,彰顯了該公司通過推動家庭血壓監測及預防性心血管護理,來延長健康壽命的長期承諾。 圖標:https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png 圖片:

More news about: Omron Healthcare Co., Ltd.


Sep 29, 2025, 12:46 ET Industry Pioneer SyberJet Announces Next Gen SJ36 Program

-- SyberJet Aircraft is pleased to announce the all-new SJ36 light jet. The next-generation, single-pilot, nine-seat jet is currently in development, with certification targeted for 2032. Evolving from the FAA-certified SyberJet SJ30-2, The SJ36 is designed to become the leader in nearly every light

More news about: SyberJet


Sep 29, 2025, 04:00 ET OMRON Healthcare Exceeds 400M Blood Pressure Monitors Sold

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Image:

More news about: OMRON HEALTHCARE Co., Ltd.


Sep 29, 2025, 04:00 ET OMRON Healthcare Exceeds 400M Blood Pressure Monitors Sold

https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202509195504/_prw_PI1fl_k2sj30Cw.png  Image:

More news about: OMRON HEALTHCARE Co., Ltd.


Sep 25, 2025, 11:35 ET Stellantis Brings Multiple Exhibits and Family Fun to the Texas Auto Show at the 2025 State Fair of Texas

place for young fans to start their journey into the world of adventureFirst-generation Jeep Cherokee Vignette – features a 1983 Jeep Cherokee SJ, the final year of the trailblazing SUV that defined adventure and set the stage for generations of Cherokee vehicles

More news about: Stellantis


Sep 11, 2025, 02:27 ET Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

migraine and medication-overuse headache in patients also receiving patient education: Results from the placebo-controlled RESOLUTION trial. Tepper SJ, et al. Saturday 13th September5 Efficacy and safety of eptinezumab in chronic migraine: Randomized controlled trial in a

More news about: H. Lundbeck A/S


Sep 11, 2025, 02:23 ET Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

migraine and medication-overuse headache in patients also receiving patient education: Results from the placebo-controlled RESOLUTION trial. Tepper SJ, et al. Saturday 13th September5 Efficacy and safety of eptinezumab in chronic migraine: Randomized controlled trial in a

More news about: H. Lundbeck A/S


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.